WASHINGTON – On Thursday, September 30, 2010 at 10:00 a.m. in Room HVC-210 of the Capitol Visitor Center, the Committee on Oversight and Government Reform will hold a hearing entitled, "Johnson & Johnson's Recall of Children's Tylenol and other Children's Medicines and the Phantom Recall of Motrin (Part 2)". This is the second hearing examining the circumstances surrounding the April 30, 2010, recall of more than 135 million bottles of Children's Tylenol and other popular pediatric medicines produced by Johnson & Johnson/McNeil Consumer Healthcare. The first hearing was held on May 27, 2010. This hearing will focus on both the broader recall announced in April of this year and on the "phantom recall" of an adult Motrin product that came to light as a result of the first hearing.

Doors open to credentialed members of the media at 9:00 a.m. and to the general public at 9:45 a.m.  A live webcast of the hearing will be available on the committee’s website: http://oversight.house.gov.

To read the witness testimony and to view a webcast of the hearing, please click here.

Witnesses scheduled to testify:

Panel I:

Mr. William C. Weldon
Chairman and Chief Executive Officer
Johnson & Johnson

Ms. Colleen Goggins
Worldwide Chairman, Consumer Group
Johnson & Johnson

Panel II:

Joshua M. Sharfstein, M.D.
Principal Deputy Commissioner
Food and Drug Administration

###